Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Goodwill & Intangibles (2009 - 2025)

Grifols' (GRFS) quarterly Goodwill & Intangibles came in at $11.1 billion in Q4 2025, up 0.83% YoY from $11.0 billion in Q4 2024, and up 0.83% on a QoQ basis from $11.0 billion in Q4 2024.

Grifols (GRFS) Goodwill & Intangibles (2009 - 2025) Analysis & Trends

Grifols (GRFS) has 17 years of Goodwill & Intangibles data on file, last reported at $11.1 billion in Q4 2025.

  • Quarterly Goodwill & Intangibles rose 0.83% year-over-year to $11.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.1 billion (up 0.83% YoY) and the FY2025 annual result came in at $11.1 billion, up 0.83% from the prior year.
  • Goodwill & Intangibles improved to $11.1 billion in Q4 2025, from $11.0 billion in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $11.1 billion in Q4 2025 to a low of $8.8 billion in Q4 2023.
  • A 5-year average of $10.0 billion and a median of $10.2 billion in 2022 frame the typical range for Goodwill & Intangibles.
  • Annual changes were most pronounced in 2023 — Goodwill & Intangibles fell 13.28% — and 2024, when it gained 25.24%.
  • Tracing GRFS's Goodwill & Intangibles over 5 years: stood at $9.0 billion in 2021, then grew by 12.94% to $10.2 billion in 2022, then slipped by 13.28% to $8.8 billion in 2023, then grew by 25.24% to $11.0 billion in 2024, then rose by 0.83% to $11.1 billion in 2025.
  • The last three Goodwill & Intangibles figures came in at $11.1 billion (Q4 2025), $11.0 billion (Q4 2024), and $8.8 billion (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Grifols 5.45 Bn 4.45 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 11.13 Bn
Dec 31, 2024 11.04 Bn
Dec 31, 2023 8.81 Bn
Dec 31, 2022 10.16 Bn
Dec 31, 2021 9.00 Bn
Dec 31, 2020 8.21 Bn
Sep 30, 2020 8.95 Bn
Mar 31, 2020 8.61 Bn
Dec 31, 2019 8.46 Bn
Sep 30, 2019 8.77 Bn
Mar 31, 2019 8.43 Bn
Dec 31, 2018 7.53 Bn
Sep 30, 2018 7.65 Bn
Jun 30, 2018 7.56 Bn
Mar 31, 2018 7.11 Bn
Dec 31, 2017 6.90 Bn
Jun 30, 2017 6.74 Bn
Dec 31, 2016 5.23 Bn
Sep 30, 2016 5.11 Bn
Jun 30, 2016 5.20 Bn